�Թϱ���

Top 20 medical device company selects Vault CDMS
for greater agility in clinical trial management

PLEASANTON, CA — July 10, 2019 — �Թϱ��� Systems (NYSE: VEEV) today announced that Alcon, a global medical device company specializing in surgical and vision care products, chose �Թϱ��� Vault Clinical Data Management System (CDMS) as its enterprise clinical data management system for electronic data capture (EDC).

�Թϱ��� Vault CDMS is a suite of clinical data management applications on a single cloud platform that enables Alcon to manage studies from build through execution in an integrated way. Vault EDC, part of Vault CDMS, provides an intuitive interface for capturing trial data and is designed for flexibility so Alcon can create study builds faster and make mid-study changes with no downtime.

As a newly independent company, Alcon had the opportunity to select modern applications that support its ambitious R&D program. Vault CDMS meets the specific requirements and fast development cycles of medical device research while adding efficiencies in trial data management.

“Rapid study startups are crucial for us because of the quick development cycles of medical device products,” said Lisa Sauls, R&D IT director, clinical and regulatory affairs, at Alcon. “�Թϱ��� Vault CDMS is an innovative, high-quality solution that offers speed and the flexibility to accommodate medical device data.”

“�Թϱ��� Vault CDMS helps life sciences companies improve agility in data management and efficiency from startup through completion,” said Henry Levy, general manager, �Թϱ��� Vault CDMS. “With its move to �Թϱ��� Vault, Alcon has the foundation to speed innovation in eye care.”

In addition to Vault CDMS, Alcon is adopting Vault PromoMats, Vault eTMF, Vault CTMS, Vault Submissions, Vault Submissions Archive, Vault QualityDocs, and Vault Training.

To see how Vault CDMS helps companies cut their EDC study build times by 40-60%, on Tuesday, July 16, 2019.

Additional Information
For more information on �Թϱ��� MedTech, visit: veeva.com/medtech
Connect with �Թϱ��� on LinkedIn:
Follow @veevasystems on Twitter:
Like �Թϱ��� on Facebook:

About Alcon
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, Alcon offer the broadest portfolio of products to enhance sight and improve people’s lives. Based in Geneva, Switzerland, and Fort Worth, Texas, the company’s surgical and vision care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. More than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at

About �Թϱ��� Systems
�Թϱ��� Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, �Թϱ��� serves more than 750 customers, ranging from the world’s largest pharmaceutical and medical device companies to emerging biotechs. �Թϱ��� is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com.

Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of �Թϱ���’s products and services, the results from use of �Թϱ���’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon �Թϱ���’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent �Թϱ���’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and �Թϱ��� disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect �Թϱ���’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended April 30, 2019. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at . Further information on potential risks that could affect actual results will be included in other filings �Թϱ��� makes with the SEC from time to time.

###

Contact:
�Թϱ��� Systems
pr@veeva.com